CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy
Ho Song Yu, Jeong Woo Lee, Jihyeong Yu, Min Chul Cho, Sung Yong Cho
Int Neurourol J. 2019;23(4):294-301.   Published online 2019 December 31
DOI: https://doi.org/10.5213/inj.1938076.038

Excel Download

A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy
International Neurourology Journal. 2019;23(4):294-301   Crossref logo
Link1 Link2 Link3

I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study
Clinical Therapeutics. 2012;34(8):1720-1734.e3   Crossref logo
Link1 Link2

I-COMBINE Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled With Amlodipine 5 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study
Clinical Therapeutics. 2012;34(8):1705-1719   Crossref logo
Link1 Link2

Effect of Doxazosin Gastrointestinal Therapeutic System 4 mg vs Tamsulosin 0.2 mg on Nocturia in Chinese Men With Lower Urinary Tract Symptoms: A Prospective, Multicenter, Randomized, Open, Parallel Study
Urology. 2011;78(3):636-640   Crossref logo
Link1 Link2

Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer’s disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial
Alzheimer's Research & Therapy. 2019;11(1):   Crossref logo
Link1 Link2 Link3

Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study
Clinical Pharmacology: Advances and Applications. 2014;63   Crossref logo
Link1

Prospective, randomized, multicenter, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus and PRP in monotherapy in the treatment of patients with high
Acta Ophthalmologica. 2012;90:0-0   Crossref logo
Link1

An open-label, dose-escalation study of ZD0473 combined with paclitaxel in refractory solid malignancies
Lung Cancer. 2000;29(1):70-71   Crossref logo
Link1 Link2

Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study
Clinical Therapeutics. 2010;32(7):1270-1284   Crossref logo
Link1 Link2

An open-label single-center study to assess the safety and efficacy of dose escalation of alefacept 15 mg IM for 6 weeks followed by 6 weeks of 30 mg IM in patients with moderate to severe chronic plaque psoriasis
Journal of the American Academy of Dermatology. 2005;52(3):P177   Crossref logo
Link1 Link2